MEDIROM Healthcare Technologies Inc. Files Its Annual Report on Form 20-F
01 6월 2023 - 8:57PM
MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic
healthcare company based in Japan (“MEDIROM” or the “Company”),
today announced it filed its annual report on Form 20-F for the
fiscal year ended December 31, 2022 with the Securities and
Exchange Commission (the "SEC") on May 30, 2023. The annual report
on Form 20-F, which contains the Company's audited consolidated
financial statements, can be accessed on the SEC's website at
http://www.sec.gov as well as through the Company's investor
relations website at https://medirom.co.jp/en/ir/.
About MEDIROM Healthcare Technologies
Inc. MEDIROM, a holistic healthcare company, operates 313
(as of April 30, 2023) relaxation salons across Japan, Re.Ra.Ku®,
being its leading brand, and provides healthcare services. In 2015,
MEDIROM entered the health tech business, and launched new
healthcare programs using on-demand training app called “Lav®”,
which is developed by the Company. MEDIROM also entered the device
business in 2020 and has developed a smart tracker “MOTHER
Bracelet®”. MEDIROM hopes that its diverse health related services
and products offering will help it collect and manage healthcare
data from users and customers and enable it to become a leader in
big data in the healthcare industry. For more information, visit
https://medirom.co.jp/en.
Forward-Looking Statements
Certain statements in this press release are forward-looking
statements for purposes of the safe harbor provisions under the
U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements may include estimates or expectations
about the Company’s possible or assumed operational results,
financial condition, business strategies and plans, market
opportunities, competitive position, industry environment, and
potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as “may,” “will,”
“should,” “design,” “target,” “aim,” “hope,” “expect,” “could,”
“intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”
“predict,” “project,” “potential,” “goal,” or other words that
convey the uncertainty of future events or outcomes. These
statements relate to future events or to the Company’s future
financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause the Company’s actual
results, levels of activity, performance, or achievements to be
different from any future results, levels of activity, performance
or achievements expressed or implied by these forward-looking
statements. . The Company’s actual results and the timing of events
could differ materially from those anticipated in such
forward-looking statements as a result of these risks and
uncertainties. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties and other factors which are, in some cases,
beyond the Company’s control and which could, and likely will,
affect actual results, levels of activity, performance or
achievements. Any forward-looking statement reflects the Company’s
current views with respect to future events and is subject to these
and other risks, uncertainties and assumptions relating to the
Company’s operations, results of operations, growth strategy and
liquidity. The Company assumes no obligation to publicly update or
revise these forward-looking statements for any reason, or to
update the reasons actual results could differ from those
anticipated in these forward-looking statements, even if new
information becomes available in the future.
Contacts
Investor Relations Team
ir@medirom.co.jp
MEDIROM Healthcare Techn... (NASDAQ:MRM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
MEDIROM Healthcare Techn... (NASDAQ:MRM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024